Related Experiment Video

Updated: Jun 3, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

Changing paradigms in the treatment of malignant pheochromocytoma

Raymon H Grogan1, Elliot J Mitmaker, Quan-Yang Duh

  • 1Department of Endocrine Surgery, University of California, San Francisco, CA 94143, USA. quan-yang.duh@med.va.gov

Cancer Control : Journal of the Moffitt Cancer Center
|April 1, 2011
PubMed
Abstract

Insights

Malignant pheochromocytomas and paragangliomas are challenging to treat. Advances in understanding molecular pathways are leading to promising new therapeutic strategies for these rare tumors.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Pheochromocytomas and paragangliomas are rare adrenal and extra-adrenal tumors.
  • Malignant transformation of these tumors presents significant treatment challenges.
  • Recent research has elucidated key molecular pathways in malignant pheochromocytoma.

Purpose of the Study:

  • To review evolving treatment strategies for malignant pheochromocytomas and paragangliomas.
  • To highlight the impact of recent molecular discoveries on therapeutic approaches.

Main Methods:

  • Literature review of recent studies and clinical trials.
  • Analysis of advances in genomics and proteomics related to pheochromocytoma.

Main Results:

  • Traditional treatments for malignant pheochromocytoma have shown limited success.
  • Novel therapeutic targets identified through genomic and proteomic research show promising outcomes.
  • New treatment strategies are emerging based on a deeper understanding of tumor biology.

Conclusions:

  • Despite promising preliminary results, further research is needed.
  • Future collaborative efforts should focus on prospective, evidence-based clinical trials.
  • Improved treatment outcomes for malignant pheochromocytomas and paragangliomas are anticipated.

Related Concept Videos

Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...